Vocalbeats.AI, a Singapore-based artificial intelligence company, has introduced Glowise, a comprehensive GLP-1 companion app that consolidates multiple aspects of weight-loss medication management into a single platform. The announcement matters because it addresses a common pain point for individuals on GLP-1 therapies: the fragmentation of health data across separate trackers, notes, and reminders. By unifying medication schedules, food and nutrition logs, hydration, side-effect notes, weight trends, and activity progress, Glowise aims to provide a coherent record that users can review over time. This integration could lead to more informed conversations with healthcare professionals, as patients can present a complete picture of their routine rather than piecing together information from disparate sources.
The app's design philosophy centers on reducing the effort required to maintain a useful record. Glowise incorporates AI-assisted logging through VoiceLog, food photos, barcode and label scans, and menu scans, offering multiple low-friction ways to capture dietary information. Importantly, these features are intended to streamline data entry, not to diagnose symptoms, recommend dose changes, or replace clinical judgment. The company emphasizes that the product is for tracking and education only, and users should consult qualified healthcare professionals for treatment decisions.
"Users are not looking for more fields to fill," said Marco Lai Jinnan, CEO of Vocalbeats.AI. The product is designed to keep medication, meals, and everyday notes close together so people can review their own routine without switching between separate trackers. This all-in-one approach is detailed on Glowise's GLP-1 tracker for the whole journey, which frames medication as only one part of the routine. For readers comparing options, the company also published a guide to the best GLP-1 tracker apps for different needs in 2026, and a focused look at the best semaglutide apps for tracking your routine.
The implications of this launch extend beyond convenience. For the growing population using GLP-1 medications, consistent tracking can be challenging, and missed or incomplete data may hinder both personal insights and clinical guidance. By lowering the barrier to logging, Glowise may improve adherence to tracking habits, which in turn could support better outcomes through more accurate self-monitoring. Additionally, the app's availability on both iPhone and Android ensures broad accessibility. As the digital health market becomes increasingly crowded, Glowise's focus on contextualizing data—rather than simply collecting numbers—could differentiate it from standalone trackers. The app is available now at glowise.app, and Vocalbeats.AI continues to expand its portfolio of AI-powered applications aimed at improving everyday life.
